Loading…
Based on limited metadata, the FDA issued a warning letter to TramadolHub on May 29, 2018, regarding an unspecified product categorized as "Other." Without access to the full letter text or subject line details, the specific nature of the violations cannot be determined from the available information. The issuing office is also not identified in the metadata provided. To understand the regulatory concerns and required corrective actions, the complete warning letter would need to be reviewed.